SMTL ID : 5tq8.1

Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.59 Å

Oligo State

monomer

Ligands

1 x 7GS: {2-[6-(2-ethyl-5-fluoro-4-hydroxyphenyl)-2H-indazol-3-yl]-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl}[5-(piperidin-1-yl)pyrazin-2-yl]methanone(Non-covalent)

7GS.1: 20 residues within 4Å: Chain A: Q.19, Q.20, L.21, K.23, V.29, A.46, K.48, E.64, L.68, L.93, M.95, E.96, Y.97, L.98, P.99, G.101, L.149, G.159, D.160, F.161 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:K.23, A:V.29, A:V.29, A:K.48, A:L.93, A:M.95 Hydrogen bonds: A:Q.19, A:E.64, A:E.64, A:L.98, A:L.98, A:F.161 Water bridges: A:Q.20, A:G.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jones, P. et al., Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. J. Med. Chem. (2017)

Release Date

2017-01-11

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence